Literature DB >> 15815892

[CT diagnosis in acute cerebral ischemia].

P Schramm1.   

Abstract

The advent of new MRI techniques such as perfusion- (PWI) and diffusion- (DWI) weighted imaging has improved diagnostic imaging in stroke. However, CT scanners are more widely available and less expensive than MRI scanners and are often located in the emergency departments even of smaller community hospitals. Topic of this article is CT-based diagnosis of patients with hyperacute ischemic stroke. In hyperacute stroke, a multiparametric CT protocol allows a comprehensive diagnosis by combining non-contrast enhanced CT (NECT), perfusion CT (PCT), and CT angiography (CTA). PCT can render important information about the hypoperfused brain tissue, CTA provides further important information about the vessel status. When stroke MRI is not available, multiparametric stroke CT can give nearly equivalent information, and can help to identify patients for thrombolytic therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15815892     DOI: 10.1007/s00117-005-1206-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  30 in total

1.  Early prediction of irreversible brain damage after ischemic stroke at CT.

Authors:  R von Kummer; H Bourquain; S Bastianello; L Bozzao; C Manelfe; D Meier; W Hacke
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke.

Authors:  S Wildermuth; M Knauth; T Brandt; R Winter; K Sartor; W Hacke
Journal:  Stroke       Date:  1998-05       Impact factor: 7.914

3.  Potential of CT angiography in acute ischemic stroke.

Authors:  M Knauth; R von Kummer; O Jansen; S Hähnel; A Dörfler; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1997 Jun-Jul       Impact factor: 3.825

4.  Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis.

Authors:  S Warach; J F Dashe; R R Edelman
Journal:  J Cereb Blood Flow Metab       Date:  1996-01       Impact factor: 6.200

5.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

6.  Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.

Authors:  J Astrup; L Symon; N M Branston; N A Lassen
Journal:  Stroke       Date:  1977 Jan-Feb       Impact factor: 7.914

7.  CT angiography in acute ischemic stroke: preliminary results.

Authors:  Piero Verro; Lawrence N Tanenbaum; Neil M Borden; Souvik Sen; Noam Eshkar
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

8.  Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset.

Authors:  Peter Schramm; Peter D Schellinger; Jochen B Fiebach; Sabine Heiland; Olav Jansen; Michael Knauth; Werner Hacke; Klaus Sartor
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

9.  Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat.

Authors:  G Mies; S Ishimaru; Y Xie; K Seo; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1991-09       Impact factor: 6.200

10.  The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study.

Authors:  H S Jørgensen; H Nakayama; H O Raaschou; K Larsen; P Hübbe; T S Olsen
Journal:  Stroke       Date:  1995-07       Impact factor: 7.914

View more
  2 in total

Review 1.  [Imaging techniques in diagnosis of brainstem infarction].

Authors:  G Schulte-Altedorneburg; H Brückmann
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 2.  [Stroke].

Authors:  F J Ahlhelm; N Naumann; A Haass; I Grunwald; G Schulte-Altedorneburg; K Fassbender; W Reith
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.